Gryl, for the Benefit of Shire Pharmaceuticals Group Plc v. Shire Pharmaceuticals Group Plc

Related Cases

Frank Gryl, for the Benefit of Shire Pharmaceuticals Group Plc and Barbara Gryl, for the Benefit of Shire Pharmaceuticals Group Plc v. Shire Pharmaceuticals Group Plc, Zola Horovitz, Ronald Nordmann and John Spitznagel
Glaxo Wellcome, Inc. v. Pharmadyne Corp.
Schering Corporation v. Geneva Pharmaceuticals, Inc. And Novartis Corporation, and Teva Pharmaceuticals Usa, Inc., and Andrx Corporation, Andrx Pharmaceuticals Llc, and Andrx Pharmaceuticals, Inc., and Mylan Pharmaceuticals, Inc., and Wyeth, Esi-Lederle, Wyeth Pharmaceuticals, and Wyeth Consumer Healthcare (Formerly American Home Products Corporation, Wyeth-Ayerst Laboratories, and Whitehall Robbins Healthcare), and Impax Laboratories, Inc., Apotex, Inc. And Novex Pharma, Copley Pharmaceutical, Inc., and Genpharm, Inc.
Schering Corporation v. Geneva Pharmaceuticals, Inc. And Novartis Corporation, and Teva Pharmaceuticals Usa, Inc., and Andrx Corporation, Andrx Pharmaceuticals Llc, and Andrx Pharmaceuticals, Inc., and Mylan Pharmaceuticals, Inc., and Wyeth, Esi-Lederle, Wyeth Pharmaceuticals, and Wyeth Consumer Healthcare (Formerly American Home Products Corporation, Wyeth-Ayerst Laboratories, and Whitehall Robbins Healthcare), and Impax Laboratories, Inc., Apotex, Inc. And Novex Pharma, Copley Pharmaceutical, Inc., and Genpharm, Inc.
Geneva Pharmaceuticals, Inc. v. Glaxosmithkline PLC

537 U.S. 1191

GRYL ET AL., FOR THE BENEFIT OF SHIRE PHARMACEUTICALS GROUP PLC
v.
SHIRE PHARMACEUTICALS GROUP PLC ET AL.

No. 02-903.

Supreme Court of United States.

February 24, 2003.

1

CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT.

2

C. A. 2d Cir. Certiorari denied. Reported below: 298 F. 3d 136.